Skip to content

A Multicenter Study of Patients treated with the EllipseTechnologies Intramedullary High Tibial Osteotomy (IM HTO) Nail System for Osteoarthritis and Varus Malalignment of the Knee

A Multicenter Study of Patients treated with the EllipseTechnologies Intramedullary High Tibial Osteotomy (IM HTO) Nail System for Osteoarthritis and Varus Malalignment of the Knee - Ellipse study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42426
Enrollment
10
Registered
2015-09-11
Start date
2019-12-03
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

arthritis

Interventions

The intervention of this research involves the use of a CE marked medical device, as this is not routinely used in the standard of care.

Sponsors

MEDPASS INTERNATIONAL
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Patient has standing varus malalignment benefitting from high tibial osteotomy correction 2. Patient is diagnosed with current osteoarthritis of the knee 3. Patient is eighteen years of age or greater 4. Patient is a candidate to be implanted with an Ellipse IM HTO System 5. If female of childbearing potential, patient presents with a negative pregnancy test and agrees to employ adequate birth control measures for the duration of the study 6. Patient understands and accepts the obligation to comply with the required follow-up visits and is logistically able to meet all study requirements 7. Patient signs informed consent for the use of their personal private data

Exclusion criteria

Exclusion criteria: 1. Patient declines to sign informed consent for the use of their personal private data 2. Varus deformity greater than 10° 3. Flexion contracture greater than 15° 4. Knee flexion under 90° 5. Medial/lateral tibial subluxation over 1 cm 6. Medial bone loss of over 3 mm 7. Inflammatory arthritis 8. Arthritis in the lateral compartment 9. Patella baja 10. Weight over 114 kg 11. Severe patellafemoral symptoms 12. Unaddressed ligamentous instability 13. Fixed flexion contracture 14. Known or suspected osteoporosis or osteopenia based on medical history and radiographic images 15. Current use of nicotine products. 16. Requires other surgical procedures at the time of the HTO surgery

Design outcomes

Primary

MeasureTime frame
Primary Efficacy Endpoint: * Weight-Bearing Line at Final Correction within ±5, 10 and 15% of baseline target

Secondary

MeasureTime frame
Secondary Efficacy Endpoints: * Absolute Difference in Weight-Bearing Line o Final Target versus actual at Final Consolidation o Baseline Target versus Final Target Change in Hip-Knee-Ankle Angle o Baseline versus Final Correction o Baseline versus Final Consolidation Change in Tibial Slope o Baseline versus Final Correction o Baseline versus Final Consolidation Time to full weight-bearing

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)